Literature DB >> 31109991

Stenotrophomonas maltophilia Differential Gene Expression in Synthetic Cystic Fibrosis Sputum Reveals Shared and Cystic Fibrosis Strain-Specific Responses to the Sputum Environment.

Graham G Willsey1, Korin Eckstrom1, Annette E LaBauve2, Lauren A Hinkel1, Kristin Schutz1, Robert J Meagher2, John J LiPuma3, Matthew J Wargo4.   

Abstract

Stenotrophomonas maltophilia is a Gram-negative opportunistic pathogen that can infect the lungs of people with cystic fibrosis (CF). The highly viscous mucus in the CF lung, expectorated as sputum, serves as the primary nutrient source for microbes colonizing this site and induces virulence-associated phenotypes and gene expression in several CF pathogens. Here, we characterized the transcriptional responses of three S. maltophilia strains during exposure to synthetic CF sputum medium (SCFM2) to gain insight into how this organism interacts with the host in the CF lung. These efforts led to the identification of 881 transcripts differentially expressed by all three strains, many of which reflect the metabolic pathways used by S. maltophilia in sputum, as well as altered stress responses. The latter correlated with increased resistance to peroxide exposure after pregrowth in SCFM2 for two of the strains. We also compared the SCFM2 transcriptomes of two S. maltophilia CF isolates to that of the acute infection strain, S. maltophilia K279a, allowing us to identify CF isolate-specific signatures in differential gene expression. The expression of genes from the accessory genomes was also differentially altered in response to SCFM2. Finally, a number of biofilm-associated genes were differentially induced in SCFM2, particularly in K279a, which corresponded to increased aggregation and biofilm formation in this strain relative to both CF strains. Collectively, this work details the response of S. maltophilia to an environment that mimics important aspects of the CF lung, identifying potential survival strategies and metabolic pathways used by S. maltophilia during infections.IMPORTANCE Stenotrophomonas maltophilia is an important infecting bacterium in the airways of people with cystic fibrosis (CF). However, compared to the other CF pathogens, S. maltophilia has been relatively understudied. The significance of our research is to provide insight into the global transcriptomic changes of S. maltophilia in response to a medium that was designed to mimic important aspects of the CF lung. This study elucidates the overall metabolic changes that occur when S. maltophilia encounters the CF lung and generates a road map of candidate genes to test using in vitro and in vivo models of CF.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  Stenotrophomonaszzm321990; cystic fibrosis; metabolism; nutrient acquisition; transcriptional regulation; virulence factors

Mesh:

Substances:

Year:  2019        PMID: 31109991      PMCID: PMC6620408          DOI: 10.1128/JB.00074-19

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  83 in total

1.  BLAT--the BLAST-like alignment tool.

Authors:  W James Kent
Journal:  Genome Res       Date:  2002-04       Impact factor: 9.043

Review 2.  Mucus clearance as a primary innate defense mechanism for mammalian airways.

Authors:  Michael R Knowles; Richard C Boucher
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

3.  MUSCLE: multiple sequence alignment with high accuracy and high throughput.

Authors:  Robert C Edgar
Journal:  Nucleic Acids Res       Date:  2004-03-19       Impact factor: 16.971

4.  Stenotrophomonas maltophilia interaction with human epithelial respiratory cells in vitro.

Authors:  L A De Vidipó; E A De Marques; E Puchelle; M C Plotkowski
Journal:  Microbiol Immunol       Date:  2001       Impact factor: 1.955

5.  The major extracellular protease of the nosocomial pathogen Stenotrophomonas maltophilia: characterization of the protein and molecular cloning of the gene.

Authors:  Sabine Windhorst; Eva Frank; Dessislava N Georgieva; Nicolay Genov; Fritz Buck; Peter Borowski; Wolfgang Weber
Journal:  J Biol Chem       Date:  2002-01-16       Impact factor: 5.157

6.  Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis.

Authors:  C H Goss; N Mayer-Hamblett; M L Aitken; G D Rubenfeld; B W Ramsey
Journal:  Thorax       Date:  2004-11       Impact factor: 9.139

Review 7.  Pathophysiology and management of pulmonary infections in cystic fibrosis.

Authors:  Ronald L Gibson; Jane L Burns; Bonnie W Ramsey
Journal:  Am J Respir Crit Care Med       Date:  2003-10-15       Impact factor: 21.405

8.  Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis.

Authors:  Julia Emerson; Margaret Rosenfeld; Sharon McNamara; Bonnie Ramsey; Ronald L Gibson
Journal:  Pediatr Pulmonol       Date:  2002-08

9.  Fimbriae and adherence of Stenotrophomonas maltophilia to epithelial cells and to abiotic surfaces.

Authors:  Doroti de Oliveira-Garcia; Monique Dall'Agnol; Mónica Rosales; Ana C G S Azzuz; Norma Alcántara; Marina B Martinez; Jorge A Girón
Journal:  Cell Microbiol       Date:  2003-09       Impact factor: 3.715

10.  Factors affecting the incidence of Stenotrophomonas maltophilia isolation in cystic fibrosis.

Authors:  Gavin R Graff; Jane L Burns
Journal:  Chest       Date:  2002-06       Impact factor: 9.410

View more
  4 in total

1.  Evaluating Metabolic Pathways and Biofilm Formation in Stenotrophomonas maltophilia.

Authors:  Cierra M Isom; Blake Fort; Gregory G Anderson
Journal:  J Bacteriol       Date:  2021-10-11       Impact factor: 3.476

2.  Organic Acids and Their Salts Potentiate the Activity of Selected Antibiotics against Pseudomonas aeruginosa Biofilms Grown in a Synthetic Cystic Fibrosis Sputum Medium.

Authors:  Xuerui Bao; Mona Bové; Tom Coenye
Journal:  Antimicrob Agents Chemother       Date:  2021-11-22       Impact factor: 5.938

3.  Effectors of the Stenotrophomonas maltophilia Type IV Secretion System Mediate Killing of Clinical Isolates of Pseudomonas aeruginosa.

Authors:  Megan Y Nas; Jeffrey Gabell; Nicholas P Cianciotto
Journal:  mBio       Date:  2021-06-29       Impact factor: 7.867

4.  Advances in the Microbiology of Stenotrophomonas maltophilia.

Authors:  Joanna S Brooke
Journal:  Clin Microbiol Rev       Date:  2021-05-26       Impact factor: 50.129

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.